The New Speciality Chemical Distributor, Prakash Dyechem of IMCD

The New Speciality Chemical Distributor, Prakash Dyechem of IMCD

IMCD, a leading distributor in the area of expertise of chemical substances and ingredients, has signed a policy to accumulate 100% of the stocks of Parkash DyeChem Private Limited, one in every of India’s main vendors of distinctiveness chemical compounds for production and printing inks.

“India is experiencing enormous boom possibilities in constructing systems in addition to in printing inks and packaging with a rising call for sustainable solutions. Joining forces with Parkash DyeChem, a frontrunner in distribution of speciality chemical compounds to those industries, will extend IMCD’s footprint and assist us enhance our marketplace position,” stated Frank Schneider, enterprise institution director IMCD coatings & construction.

“We are thrilled to come to be a strategic addition to IMCD India, with their robust international presence in speciality chemical compounds and comparable mind-set it flawlessly synergises with Parkash DyeChem” stated Naresh Arora, founding father of Parkash DyeChem.

“The mixture of IMCD and Parkash DyeChem is an interesting possibility to reshape the coatings and construction, non-public care and superior substances industries in a way so as to be useful for our clients and international partners,” stated Chirag Arora, director of Parkash DyeChem.

Established in 1988 and established in Delhi, Parkash DyeChem is an asset mild speciality chemical distributor serving the coatings and production segments (example production chemicals, printing inks, paints and coatings) in addition to private care and superior substances markets.
With around 60 employees, Parkash DyeChem generated a sale of about Rs. 250 crore (EUR 30 million) in the economic year that ended on March 31, 2022. The organization represents main worldwide providers and serves a huge institution of clients with an intensive portfolio of merchandise along industrial and technical support.



Leave a Reply